Finance Updates – Finance Updates

Medline’s $7.2B IPO Soars 40%: Debt Reduction, Growth Drive Investor Buzz

Americas Markets Health Care and Social Assistance

Medline priced an upsized IPO at $29 per shar...

Roughly 179 million shares’ proceeds will pay...

The remainder of proceeds will redeem equity ...

The deal, the largest U.S. IPO since 2021, sa...

Medline IPO Rockets to ~$40, Raising $6.26B: Valuation Hits $50–$55B

Americas Markets Health Care and Social Assistance

Medline’s IPO raised about $6.3 billion at $2...

The company will use most proceeds to pay dow...

Strong first-day trading and rich valuation m...

The deal’s scale and PE backing could reopen ...

What IASIS Healthcare’s IPO Withdrawal Reveals About Hospital Finance Challenges

Americas M&A Ambulatory Health Care Services

IASIS Healthcare, a private equity-backed hos...

The company owned 15 acute care hospitals, on...

IASIS withdrew its roughly US$300 million IPO...

In 2017, Steward Health Care acquired IASIS’s...

2025 Biopharma M&A Booms: Patent Cliff Spurs Big Pharma to Secure Late-Stage Assets

Global M&A Health Care and Social Assistance

Biopharma M&A in 2025 shifted to fewer but mu...

Headline acquisitions such as J&J–Intra-Cellu...

Patent cliffs threaten roughly $180–230 billi...

Deal structures feature heavier use of milest...

How 340B, ACA Subsidy Rollbacks & PBM Reform Will Reshape Strategy for Insurers & Health Providers

Americas Policy Health Care and Social Assistance

In 2025, Republicans shifted from defending A...

GOP legislative focus centered on tightening ...

A federal court halted HRSA’s 340B Rebate Mod...

With enhanced ACA subsidies set to lapse at t...

Q3 US Equity Roundup: Dividend Growth Holds While S&P Trails Amid Policy, Inflation Risks

Americas Markets Health Care and Social Assistance

Bristol Gate’s US Equity Strategy posted posi...

The portfolio’s edge remains its focus on hig...

Healthcare holdings like UnitedHealth and The...

Management is tilting further toward resilien...

Feinstein-Blum Allegations: Allogene Trades, Blind Trusts & Ethics in Senate

Americas Policy Health Care and Social Assistance

In early 2020, Sen. Dianne Feinstein’s husban...

Feinstein says the assets were in a blind tru...

The FBI questioned Feinstein, but the Justice...

The episode highlights ongoing concerns about...

Feinstein-Blum Allogene Trades: What Reputational Fallout Says About Insider Risk

Americas Risk Health Care and Social Assistance

Sen. Dianne Feinstein’s husband, Richard Blum...

Additional Allogene sales on February 18 brou...

Feinstein says her assets are in a blind trus...

The timing of the trades, amid early coronavi...

EIB’s New Direction: Scaling TechEU, Innovation Finance & Health Autonomy

Europe Tech Health Care and Social Assistance

The European Investment Bank is pivoting from...

Its TechEU programme will deploy €70 billion ...

Recent deals in biotech and digital health (A...

Success hinges on execution quality, attracti...

Feinstein-Blum & Allogene: What We Know — Insider Trading Allegations, Blind Trust Gaps

Americas Risk Health Care and Social Assistance

Sen. Dianne Feinstein’s husband, Richard Blum...

The trades occurred just before markets broad...

Feinstein says she had no role in the trades,...

Although the sales drew public scrutiny along...